|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.22 EUR | -0.05% |
|
-8.87% | +15.52% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 07-08 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
| Market Cap | 29.4B 25.76B 23.75B 21.95B 41.61B 2,804B 42.3B 284B 111B 1,381B 110B 108B 4,753B | P/E 2026 * |
30.3x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 34.91B 30.59B 28.2B 26.06B 49.41B 3,329B 50.23B 337B 132B 1,640B 131B 128B 5,644B | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 3.16x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | -0.05% | ||
| 1 week | -8.87% | ||
| Current month | +4.55% | ||
| 1 month | +4.55% | ||
| 3 months | +16.99% | ||
| 6 months | +7.82% | ||
| Current year | +15.52% |
| 1 week | 173.22 |  | 193 |
| 1 month | 173.22 | | 193 |
| Current year | 134.7 | | 193 |
| 1 year | 103.75 | | 193 |
| 3 years | 99 | | 255.6 |
| 5 years | 99 | | 317.45 |
| 10 years | 99 | | 351.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 13/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 28/02/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 22/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 31/12/2009 |
William Hawkins
BRD | Director/Board Member | 72 | 18/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.05% | -8.87% | - | - | 29.4B | |
| -0.51% | +1.57% | +18.72% | -5.52% | 67.61B | |
| -5.16% | -8.63% | +37.37% | +202.27% | 51.6B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 43B | |
| -2.10% | +0.89% | -49.30% | -53.47% | 40.94B | |
| -10.83% | -14.41% | +99.15% | -44.54% | 27.09B | |
| -1.53% | -0.13% | +65.92% | +88.58% | 23.32B | |
| +3.88% | +2.16% | +11.78% | +201.51% | 19.89B | |
| -1.59% | -1.63% | +61.04% | +130.75% | 16.91B | |
| -4.75% | +11.27% | +85.63% | +394.76% | 16.84B | |
| Average | -1.74% | -0.90% | +41.09% | +105.98% | 34.13B | |
| Weighted average by Cap. | -1.54% | -1.58% | +31.92% | +75.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.05B 8.81B 8.12B 7.5B 14.23B 959B 14.47B 97.02B 38.06B 472B 37.75B 36.93B 1,625B | 10.38B 9.1B 8.39B 7.75B 14.7B 990B 14.94B 100B 39.3B 488B 38.98B 38.14B 1,679B |
| Net income | 1.49B 1.31B 1.21B 1.12B 2.12B 143B 2.15B 14.42B 5.66B 70.22B 5.61B 5.49B 242B | 1.97B 1.72B 1.59B 1.47B 2.79B 188B 2.83B 19B 7.45B 92.49B 7.39B 7.23B 318B |
| Net Debt | 5.51B 4.83B 4.45B 4.11B 7.8B 525B 7.93B 53.16B 20.85B 259B 20.68B 20.23B 891B | 3.38B 2.97B 2.73B 2.53B 4.79B 323B 4.87B 32.66B 12.81B 159B 12.71B 12.43B 547B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | €173.22 | -0.05% | 30 |
| 09/07/26 | €173.30 | -9.12% | 0 |
| 06/07/26 | €190.70 | +0.33% | 55 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
- IDP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
